Learn More
Medchemexpress LLC 4-quinolinecarboxamide, 2-(4-ethoxyphenyl)-n-[3-(2-methyl-1-piperidinyl)propyl]- | 689270-18-6 | 99.9% | 431.57 g/mol | C27H33N3O2 | 10 MG

Supplier: Medchemexpress LLC HY14965210MG
IRF5-IN-1 is a small-molecule research compound that blocks IRF5 activation and downstream TLR7/8 signaling, producing anti-inflammatory effects observed in in vitro studies. Supplied as an off-white to light yellow solid, it is intended for biochemical and cell-based assays after dissolution in appropriate solvents (DMSO recommended). Follow recommended storage and handling conditions for experimental reproducibility.
- Selective inhibition of IRF5-mediated signaling in cellular assays.
- High purity (~99.9%) suitable for research applications.
- Soluble in DMSO at 50 mg/mL with ultrasonic warming to 80°C.
- Supplied as a 10 mg powder for small-scale experiments.
- Stable when stored as powder at -20°C, with defined in-solution stability.
- Useful tool for studying TLR7/8-IRF5 inflammatory pathways.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.